← MyLongPath

Rapamicin

Medication0 reviews
—
Average score out of 5

An mTOR-inhibiting immunosuppressant originally used to prevent transplant rejection, studied at low intermittent doses for its effects on autophagy, chronic inflammation and cellular senescence. Explored off-label in Long COVID and ME/CFS for fatigue and post-exertional malaise.

Information
Subcategory
mTOR inhibitor (immunosuppressant)
Evidence type
open-label pilot trial and preclinical data
Share your experience

Your feedback helps thousands of people find what really works.

Join the community